Sudhir Raghavan

846 total citations
31 papers, 705 citations indexed

About

Sudhir Raghavan is a scholar working on Molecular Biology, Organic Chemistry and Rheumatology. According to data from OpenAlex, Sudhir Raghavan has authored 31 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Organic Chemistry and 6 papers in Rheumatology. Recurrent topics in Sudhir Raghavan's work include Synthesis and biological activity (10 papers), Biochemical and Molecular Research (9 papers) and Quinazolinone synthesis and applications (6 papers). Sudhir Raghavan is often cited by papers focused on Synthesis and biological activity (10 papers), Biochemical and Molecular Research (9 papers) and Quinazolinone synthesis and applications (6 papers). Sudhir Raghavan collaborates with scholars based in United States, Canada and China. Sudhir Raghavan's co-authors include Aleem Gangjee, Harvey C. Gonick, B. Dwight Culver, Michael A. Ihnat, Ernest Hamel, Susan L. Mooberry, Nilesh Zaware, Larry H. Matherly, Roy L. Kisliuk and Zhanjun Hou and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Sudhir Raghavan

30 papers receiving 669 citations

Peers

Sudhir Raghavan

HTM

RHEUM

Mi Yan China

T. A. Stoming United States

Lorri L. Short United States

Pamela K. Smitherman United States

Donna L. Dehn United States

Karol Białkowski Poland

Y. Naitoh Japan

Takako Ikeda Japan

Susumu Akasaka Japan

Kathrin Sundberg Sweden

Mi Yan China

Sudhir Raghavan

296 ×0.8

393 ×1.3

14 ×0.1

HTM

25 ×0.3

RHEUM

38 ×0.5

Citations per year, relative to Sudhir Raghavan Sudhir Raghavan (= 1×) peers Mi Yan

Countries citing papers authored by Sudhir Raghavan

Since Specialization

Citations

This map shows the geographic impact of Sudhir Raghavan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sudhir Raghavan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sudhir Raghavan more than expected).

Fields of papers citing papers by Sudhir Raghavan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sudhir Raghavan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sudhir Raghavan. The network helps show where Sudhir Raghavan may publish in the future.

Co-authorship network of co-authors of Sudhir Raghavan

This figure shows the co-authorship network connecting the top 25 collaborators of Sudhir Raghavan. A scholar is included among the top collaborators of Sudhir Raghavan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sudhir Raghavan. Sudhir Raghavan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ijare, Omkar B., et al.. (2024). Targeting the Leloir Pathway with Galactose-Based Antimetabolites in Glioblastoma. Cancers. 16(20). 3510–3510. 1 indexed citations

Raghavan, Sudhir, David S. Baskin, & Martyn A. Sharpe. (2020). A ”Clickable” Probe for Active MGMT in Glioblastoma Demonstrates Two Discrete Populations of MGMT. Cancers. 12(2). 453–453. 8 indexed citations

Raghavan, Sudhir, David S. Baskin, & Martyn A. Sharpe. (2020). MP-Pt(IV): A MAOB-Sensitive Mitochondrial-Specific Prodrug for Treating Glioblastoma. Molecular Cancer Therapeutics. 19(12). 2445–2453. 4 indexed citations

Pisaneschi, Federica, Yu-Hsi Lin, Paul G. Leonard, et al.. (2019). The 3S Enantiomer Drives Enolase Inhibitory Activity in SF2312 and Its Analogues. Molecules. 24(13). 2510–2510. 8 indexed citations

Raghavan, Sudhir, et al.. (2018). Development and validation of chemical features-based proton-coupled folate transporter/activity and reduced folate carrier/activity models (pharmacophores). Journal of Molecular Graphics and Modelling. 81. 125–133.

Sharpe, Martyn A., Sudhir Raghavan, & David S. Baskin. (2018). PAM-OBG: A monoamine oxidase B specific prodrug that inhibits MGMT and generates DNA interstrand crosslinks, potentiating temozolomide and chemoradiation therapy in intracranial glioblastoma. Oncotarget. 9(35). 23923–23943. 10 indexed citations

Satani, Nikunj, et al.. (2016). ENOblock Does Not Inhibit the Activity of the Glycolytic Enzyme Enolase. PLoS ONE. 11(12). e0168739–e0168739. 22 indexed citations

Golani, Lalit K., Adrianne Wallace-Povirk, Jennifer Wong-Roushar, et al.. (2016). Tumor Targeting with Novel 6-Substituted Pyrrolo [2,3-d] Pyrimidine Antifolates with Heteroatom Bridge Substitutions via Cellular Uptake by Folate Receptor α and the Proton-Coupled Folate Transporter and Inhibition of de Novo Purine Nucleotide Biosynthesis. Journal of Medicinal Chemistry. 59(17). 7856–7876. 28 indexed citations

Wang, Lei, Adrianne Wallace-Povirk, Sudhir Raghavan, et al.. (2015). 6-Substituted Pyrrolo[2,3-d]pyrimidine Thienoyl Regioisomers as Targeted Antifolates for Folate Receptor α and the Proton-Coupled Folate Transporter in Human Tumors. Journal of Medicinal Chemistry. 58(17). 6938–6959. 35 indexed citations

10.

Zhang, Xin, Sudhir Raghavan, Michael A. Ihnat, et al.. (2015). The design, synthesis and biological evaluation of conformationally restricted 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multi-targeted receptor tyrosine kinase and microtubule inhibitors as potential antitumor agents. Bioorganic & Medicinal Chemistry. 23(10). 2408–2423. 33 indexed citations

11.

Wang, Yiqiang, et al.. (2015). Novel 5-Substituted Pyrrolo[2,3-d]pyrimidines as Dual Inhibitors of Glycinamide Ribonucleotide Formyltransferase and 5-Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase and as Potential Antitumor Agents. Journal of Medicinal Chemistry. 58(3). 1479–1493. 19 indexed citations

12.

Zhang, Xin, Sudhir Raghavan, Michael A. Ihnat, et al.. (2014). The design and discovery of water soluble 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multitargeted receptor tyrosine kinase inhibitors and microtubule targeting antitumor agents. Bioorganic & Medicinal Chemistry. 22(14). 3753–3772. 43 indexed citations

13.

Gangjee, Aleem, Nilesh Zaware, Sudhir Raghavan, et al.. (2013). Synthesis and biological activity of 5-chloro-N4-substituted phenyl-9H-pyrimido[4,5-b]indole-2,4-diamines as vascular endothelial growth factor receptor-2 inhibitors and antiangiogenic agents. Bioorganic & Medicinal Chemistry. 21(7). 1857–1864. 19 indexed citations

14.

Gangjee, Aleem, Ojas A. Namjoshi, Sudhir Raghavan, et al.. (2013). Design, Synthesis, and Molecular Modeling of Novel Pyrido[2,3-d]pyrimidine Analogues As Antifolates; Application of Buchwald–Hartwig Aminations of Heterocycles. Journal of Medicinal Chemistry. 56(11). 4422–4441. 37 indexed citations

15.

Gangjee, Aleem, Nilesh Zaware, Sudhir Raghavan, et al.. (2012). Synthesis of N4-(substituted phenyl)-N4-alkyl/desalkyl-9H-pyrimido[4,5-b]indole-2,4-diamines and identification of new microtubule disrupting compounds that are effective against multidrug resistant cells. Bioorganic & Medicinal Chemistry. 21(4). 891–902. 15 indexed citations

16.

Gangjee, Aleem, Nilesh Zaware, Sudhir Raghavan, et al.. (2012). N4-(3-Bromophenyl)-7-(substituted benzyl) pyrrolo[2,3-d]pyrimidines as potent multiple receptor tyrosine kinase inhibitors: Design, synthesis, and in vivo evaluation. Bioorganic & Medicinal Chemistry. 20(7). 2444–2454. 16 indexed citations

17.

Gangjee, Aleem, et al.. (2010). Design, synthesis and evaluation of 2-amino-4-m-bromoanilino-6-arylmethyl-7H-pyrrolo[2,3-d]pyrimidines as tyrosine kinase inhibitors and antiangiogenic agents. Bioorganic & Medicinal Chemistry. 18(14). 5261–5273. 20 indexed citations

18.

Gangjee, Aleem, Ying Zhao, Lu Lin, et al.. (2010). Synthesis and Discovery of Water-Soluble Microtubule Targeting Agents that Bind to the Colchicine Site on Tubulin and Circumvent Pgp Mediated Resistance. Journal of Medicinal Chemistry. 53(22). 8116–8128. 63 indexed citations

19.

Raghavan, Sudhir, B. Dwight Culver, & Harvey C. Gonick. (1980). Erythrocyte lead-binding protein after occupational exposure. Environmental Research. 22(1). 264–270. 49 indexed citations

20.

Khan, A. A., et al.. (1970). Studies on serratia marcescens L-asparaginase. Biochemical and Biophysical Research Communications. 41(3). 525–533. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact